REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

NCT07410117 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

860

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer-Associated Thrombosis (CAT)

Interventions

DRUG: REGN7508
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals